As the COVID-19 pandemic enters its fourth year, this report identifies four key lessons from the failure of States and pharmaceutical companies to comply with their human rights obligations and responsibilities to ensure fair access to COVID-19 vaccines globally.

This evaluation found that overall, pandemic impacts on vaccination uptake in adolescents were relatively limited in Australia compared to other countries. However, the number of adolescent vaccinations given in 2020 and 2021 was lower than in 2019.

This strategy document outlines the Australian government health supports to manage COVID-19 over the next 12 months. These health supports have been informed by the likely 2023 Australian epidemiological outlook and advice from the Chief Medical Officer.

Amid the rollout of updated COVID-19 booster shots around the United States, this Pew Research Center survey report finds mixed views of public health officials at the forefront of the nation’s response to the pandemic.

With the rise in COVID-19-attributed deaths, it is increasingly important to examine inequities in the direct health effects of COVID-19 across the New Zealand population. The Public Health Agency has undertaken exploratory analysis of COVID-19-attributed mortality to identify and quantify inequities in the burden of...

Professor Jane Halton AO has submitted the final report of her independent review of Australia’s COVID-19 vaccine and treatment procurements to the Albanese Government. This publication contains the executive summary and recommendations from the report.

The objective of this audit was to assess the effectiveness of the planning and implementation of Australia's COVID-19 vaccine rollout.

This report provides an assessment of state and territory performance against the performance benchmarks outlined in the National Partnership on Essential Vaccines, for the assessment period 1 April 2020 to 31 March 2021.

In this article, we critically review the development and implementation of COVID-19 vaccination in Singapore and China during the pandemic. Methods: We collect and analyze data from a range of sources, including scholarly articles, statistics and documents from national governments in the two countries, and...

This report summarises the reflections from an online forum convened by COSSI and NCIRS, and supported by the Australian Department of Health, on 3 March 2022.

This research paper provides a snapshot of the state of Victoria’s arts and entertainment sector between October 2021 and mid-January 2022, as restrictions eased in line with vaccination rates rising. It also explores how state and local governments in Victoria implemented policy and allocated finances...

In October 2021, the Australian government commenced the rollout of COVID-19 booster vaccines, making them available to adults who had previously received two primary doses. Despite the wide availability of booster vaccines to eligible adults, take-up has remained relatively low. This paper highlights that in...

This inquiry was established to to identify and address any vulnerabilities that had or potentially could emerge, in relation to vaccine and vaccine related fraud and security, and provide the Australian public with confidence in the integrity of the COVID-19 vaccination program.

This report argues that, despite receiving billions in public funding, a number of pharmaceutical companies are continuing to put their own business interests before their human rights responsibilities by creating barriers to fair access to their COVID-19 vaccines through their decisions not to share intellectual...

The COVID-19 vaccination programme has been one of the few almost unqualified successes of the UK’s response to the pandemic. Based on interviews with a wide range of people involved in the programme, this report sets out what the roll-out in England has achieved, as...

This report explores the complex social and cultural reasons that Māori may be less likely to engage with childhood vaccination services

This paper outlines findings from a segmentation study conducted in May-June 2021 by Monash and Massey Universities. The research identifies five different COVID vaccine audience segments and what motivates them to get or not get vaccinated, to support the tailoring of campaign messaging for maximum...

This research report examines the health risks posed to young children from COVID-19, the risk of children transmitting the virus, and the strategies that early learning centres need to implement to reduce the risk of transmission.

The purpose of this document is to offer guidance to other agencies in the development and delivery of vaccine hubs for people experiencing or at risk of homelessness. The model of care described here is also relevant to vaccination efforts targeting other hard to reach...

The COVID-19 pandemic will not end for anyone, until it ends for everyone. Through seven key recommendations, this report makes the case for an ambitious, expansive and intelligent investment to vaccinate the world.

Prime Minister Scott Morrison says businesses can refuse entry to unvaccinated patrons without falling foul of discrimination laws. Verdict: Mr Morrison's claim is not the full story.

Despite prioritisation, levels of vaccinations among children and young people with disability lag those of the general population. This report includes data from a survey undertaken by Children and Young People with Disability Australia (CYDA) and analysed by academics at the University of New South...

In May 2021, the Royal Commission conducted a public hearing in Sydney considering the experiences of people with disability, in the context of the Australian government’s approach to the COVID-19 vaccine rollout. This is the report of the three Commissioners who participated in the hearing.

The objective of this audit was to assess the effectiveness of the Australian Department of Health’s approach to improving and monitoring immunisation coverage.

This report focuses on six leading vaccine developers, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.